Altimmune, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Altimmune, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Altimmune, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.66M, a 291% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.66M +$1.24M +291% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.68M +$1.19M +246% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $300K -$241K -44.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $363K -$233K -39.1% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $424K -$225K -34.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $484K -$217K -31% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $541K -$209K -27.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $596K -$202K -25.3% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $649K -$195K -23.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $701K -$126K -15.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $750K -$116K -13.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $798K -$106K -11.7% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $844K -$95.6K -10.2% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $827K +$165K +25% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $866K +$186K +27.2% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $904K +$206K +29.4% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $940K +$223K +31% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $662K -$70.3K -9.6% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $681K -$64.1K -8.61% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $698K Dec 31, 2019 10-K 2021-02-25
Q3 2019 $717K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $732K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $745K Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.